0,799  0,005  Respiratory analeptic
0,783  0,004  Spasmolytic
0,770  0,004  5 Hydroxytryptamine release stimulant
0,752  0,004  CYP2D6 inhibitor
0,734  0,004  CYP2C19 inhibitor
0,673  0,021  Antineoplastic (lung cancer)
0,650  0,005  Cardiodepressant
0,648  0,012  Antidepressant
0,645  0,024  CYP3A4 substrate
0,628  0,011  Analeptic
0,629  0,015  Mood disorders treatment
0,605  0,003  Antiparkinsonian, rigidity relieving
0,627  0,033  Caspase 9 stimulant
0,596  0,004  Sigma receptor agonist
0,622  0,044  Apoptosis agonist
0,582  0,005  Muscle relaxant
0,595  0,019  Antiparkinsonian
0,604  0,034  Antineoplastic (breast cancer)
0,553  0,008  CYP3A4 inhibitor
0,567  0,022  Prostate cancer treatment
0,539  0,005  Skeletal muscle relaxant
0,540  0,015  Caspase 3 stimulant
0,557  0,037  Transcription factor NF kappa B inhibitor
0,539  0,019  Antineoplastic (melanoma)
0,524  0,005  Cholinergic antagonist
0,523  0,005  Acetylcholine antagonist
0,528  0,018  Hepatic disorders treatment
0,533  0,030  CYP2C9 substrate
0,513  0,023  CYP2D6 substrate
0,510  0,038  Antileukemic
0,464  0,004  Neurotrophic factor enhancer
0,470  0,014  Psychostimulant
0,481  0,026  CYP1A2 substrate
0,449  0,004  Alpha 2 adrenoreceptor antagonist
0,460  0,038  Vasodilator, peripheral
0,437  0,022  Hypoxia-inducible factor 1 alpha inhibitor
0,417  0,005  Acetylcholine muscarinic antagonist
0,403  0,005  Antitussive
0,392  0,006  Acetylcholine M1 receptor antagonist
0,418  0,033  Antineoplastic (glioma)
0,429  0,047  Antineoplastic (colorectal cancer)
0,393  0,014  Hepatoprotectant
0,424  0,045  Antineoplastic (colon cancer)
0,417  0,041  Antineoplastic (ovarian cancer)
0,389  0,027  Urologic disorders treatment
0,391  0,029  Antineoplastic (glioblastoma multiforme)
0,349  0,004  Dopamine uptake inhibitor
0,409  0,071  Histamine release inhibitor
0,351  0,013  Cholinergic
0,342  0,016  Antineoplastic (squamous cell carcinoma)
0,368  0,046  CYP2C19 substrate
0,346  0,026  Abortion inducer
0,350  0,040  Sodium/bile acid cotransporter inhibitor
0,321  0,022  Urinary incontinence treatment
0,352  0,054  Vasodilator, coronary
0,335  0,040  Antineoplastic (renal cancer)
0,335  0,045  DNA damaging
0,296  0,008  LDLR expression enhancer
0,342  0,056  NOS3 expression inhibitor
0,287  0,003  Antineoplastic alkaloid
0,333  0,060  Antipsychotic
0,326  0,059  Antineoplastic (pancreatic cancer)
0,277  0,013  Topoisomerase I inhibitor
0,314  0,052  Antineoplastic (non-small cell lung cancer)
0,281  0,020  Antiparkinsonian, tremor relieving
0,270  0,012  Uterine stimulant
0,281  0,025  Lipocortins synthesis antagonist
0,345  0,089  Immunosuppressant
0,271  0,018  Alpha adrenoreceptor antagonist
0,320  0,069  Anxiolytic
0,310  0,060  Antineoplastic (multiple myeloma)
0,255  0,005  Acetylcholine M3 receptor antagonist
0,282  0,033  P-glycoprotein inhibitor
0,262  0,016  Antiadrenergic
0,253  0,008  Dopamine D1 antagonist
0,281  0,038  Anesthetic general
0,306  0,065  Radioprotector
0,256  0,016  Adrenaline antagonist
0,251  0,014  Dopamine antagonist
0,254  0,020  Acetylcholinesterase inhibitor
0,288  0,056  Antineoplastic (liver cancer)
0,266  0,036  UGT2B7 substrate
0,293  0,063  Antihypercholesterolemic
0,252  0,024  Topoisomerase II inhibitor
0,237  0,012  Alpha 2c adrenoreceptor antagonist
0,238  0,013  Antismoking
0,270  0,046  Nitric oxide antagonist
0,235  0,017  Alpha 2b adrenoreceptor antagonist
0,226  0,011  Alpha 2a adrenoreceptor antagonist
0,345  0,131  Alzheimer's disease treatment
0,246  0,042  Pneumotoxic
0,251  0,049  Sedative
0,228  0,027  Genotoxic
0,220  0,023  Antiviral (Hepatitis B)
0,227  0,033  Prostate disorders treatment
0,257  0,068  5 Hydroxytryptamine 1E antagonist
0,250  0,066  DNA synthesis inhibitor
0,221  0,038  Antineoplastic (carcinoma)
0,193  0,010  Dopamine agonist
0,248  0,068  Antineoplastic (lymphoma)
0,211  0,031  5 Hydroxytryptamine antagonist
0,183  0,005  Restless leg syndrome treatment
0,211  0,035  Toxic, respiratory center
0,180  0,008  Acetylcholine M2 receptor antagonist
0,218  0,047  Prostatic (benign) hyperplasia treatment
0,188  0,018  Constipation treatment
0,180  0,010  CDC-like kinase 3 inhibitor
0,172  0,008  Antiprotozoal activity enhancer
0,215  0,053  Male reproductive disfunction treatment
0,238  0,076  Vasodilator
0,199  0,040  UGT2B9 substrate
0,174  0,016  Acetylcholine nicotinic antagonist
0,197  0,039  Phobic disorders treatment
0,164  0,006  Nicotinic alpha4beta2 receptor antagonist
0,279  0,122  Cognition disorders treatment
0,218  0,061  UDP-glucuronosyltransferase substrate
0,198  0,042  Protein kinase stimulant
0,231  0,076  Cytostatic
0,197  0,045  Antiviral (Influenza A)
0,245  0,093  UGT2B4 substrate
0,163  0,013  Acetylcholine M3 receptor agonist
0,182  0,032  Alkylator
0,179  0,030  Adenylate cyclase inhibitor
0,239  0,090  UGT1A9 substrate
0,189  0,041  Carcinogenic, group 1
0,216  0,068  Antiarrhythmic
0,221  0,073  Sensitization
0,285  0,140  15-Lipoxygenase inhibitor
0,209  0,065  Mutagenic
0,209  0,066  UGT1A1 substrate
0,163  0,021  Dopamine D2 antagonist
0,153  0,015  5 Hydroxytryptamine uptake inhibitor
0,172  0,035  DNA intercalator
0,250  0,113  Bone diseases treatment
0,198  0,061  Antiviral (Hepatitis)
0,158  0,026  5 Hydroxytryptamine 2A antagonist
0,169  0,038  5 Hydroxytryptamine 2 antagonist
0,202  0,073  Antiviral (Influenza)
0,273  0,148  TNF expression inhibitor
0,138  0,013  Acetylcholine M4 receptor antagonist
0,214  0,092  NOS2 expression inhibitor
0,244  0,123  Antineoplastic (brain cancer)
0,149  0,032  Antiemetic
0,220  0,103  Cardiotonic
0,199  0,084  Antimitotic
0,180  0,065  Liver fibrosis treatment
0,166  0,054  Erectile dysfunction treatment
0,124  0,012  Acetylcholine M5 receptor antagonist
0,115  0,004  Prolactin release inhibitor
0,174  0,063  UGT2B10 substrate
0,169  0,058  Hair growth stimulant
0,118  0,008  Dopamine D5 antagonist
0,191  0,082  Cytotoxic
0,218  0,110  Immunostimulant
0,165  0,059  Lipid peroxidase inhibitor
0,238  0,133  Interleukin 2 agonist
0,142  0,039  Alcohol dehydrogenase substrate
0,121  0,020  Dopamine D3 antagonist
0,119  0,018  Neuronal nicotinic receptor antagonist
0,116  0,015  Adrenaline uptake inhibitor
0,140  0,043  Microtubule formation inhibitor
0,102  0,008  Nitric oxide donor
0,158  0,064  CDC-like kinase 1 inhibitor
0,192  0,099  Teratogen
0,163  0,070  Cystic fibrosis treatment
0,152  0,060  Adenylate cyclase stimulant
0,099  0,008  Nicotinic alpha3beta2 receptor antagonist
0,162  0,074  UGT1A3 substrate
0,130  0,042  Butyrylcholinesterase inhibitor
0,114  0,028  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,127  0,042  Estrogen antagonist
0,204  0,120  Proliferative diseases treatment
0,226  0,143  Antihypertensive
0,120  0,037  Alpha 1 adrenoreceptor antagonist
0,205  0,122  Antiosteoporotic
0,197  0,115  Antioxidant
0,109  0,029  Opioid kappa receptor antagonist
0,246  0,168  CYP2C9 inhibitor
0,105  0,028  Phosphodiesterase XI inhibitor
0,105  0,028  Phosphodiesterase 11A inhibitor
0,092  0,015  Glutamate (mGluR7) antagonist
0,103  0,027  Sodium/hydrogen exchanger 5 inhibitor
0,218  0,143  AR expression inhibitor
0,177  0,102  Embryotoxic
0,115  0,042  Prolactin inhibitor
0,137  0,065  Tubulin antagonist
0,121  0,050  Expectorant
0,084  0,013  Dopamine D2 agonist
0,082  0,012  Acetylcholine M2 receptor agonist
0,112  0,042  Estrogen receptor beta antagonist
0,200  0,131  Cardioprotectant
0,153  0,084  UGT1A4 substrate
0,182  0,114  Antineoplastic (cervical cancer)
0,073  0,005  p53 inhibitor
0,150  0,082  Melanin inhibitor
0,291  0,224  Antiinflammatory
0,103  0,038  Topoisomerase II alpha inhibitor
0,137  0,071  Contraceptive
0,082  0,016  Dopamine transporter inhibitor
0,078  0,014  Nicotinic receptor alpha4 subunit antagonist
0,106  0,043  Acetylcholine agonist
0,106  0,044  Calcium antagonist
0,100  0,039  ATPase (Vacuolar H+) inhibitor
0,072  0,011  Adenylate cyclase 1 inhibitor
0,143  0,086  Chemopreventive
0,107  0,052  Antineoplastic, alkylator
0,071  0,016  Alpha-mannosidase inhibitor
0,074  0,020  Nicotinic receptor alpha7 subunit antagonist
0,088  0,034  Phosphodiesterase V inhibitor
0,078  0,025  Alpha 2 adrenoreceptor agonist
0,181  0,127  Myocardial infarction treatment
0,088  0,036  Narcotic antagonist
0,084  0,034  Antitreponemal
0,099  0,050  SULT1E1 substrate
0,085  0,038  Opioid mu receptor antagonist
0,136  0,089  Ca2+-transporting ATPase inhibitor
0,097  0,050  Opioid antagonist
0,060  0,017  Factor III inhibitor
0,080  0,037  Premenstrual syndrome treatment
0,209  0,167  Apoptosis antagonist
0,125  0,083  Antifungal enhancer
0,167  0,126  Cyclic AMP phosphodiesterase inhibitor
0,060  0,019  Nicotinic receptor alpha3 subunit antagonist
0,083  0,044  Alpha 1a adrenoreceptor antagonist
0,097  0,058  Phosphodiesterase 6D inhibitor
0,065  0,027  Alpha tubulin antagonist
0,065  0,030  Acetylcholine muscarinic agonist
0,085  0,050  Glycine receptor antagonist
0,064  0,030  Postmenopausal disorders treatment
0,063  0,030  Lipocortins synthesis agonist
0,080  0,049  Estrogen receptor alpha antagonist
0,097  0,066  Anabolic
0,053  0,022  Opioid kappa receptor agonist
0,108  0,079  Menstruation disorders treatment
0,052  0,023  Mannosidase inhibitor
0,074  0,046  Phosphodiesterase 5A inhibitor
0,048  0,020  Neurokinin 1 antagonist
0,034  0,007  Dopamine D1 agonist
0,070  0,043  SULT2A1 substrate
0,171  0,145  Peptidyltransferase inhibitor
0,094  0,069  UGT2B11 substrate
0,033  0,008  Endothelin B receptor antagonist
0,038  0,013  Endothelin receptor antagonist
0,129  0,104  Pregnane X receptor agonist
0,117  0,094  Attention deficit/hyperactivity disorder treatment
0,145  0,123  Antineoplastic (bone cancer)
0,048  0,026  Phosphodiesterase 6C inhibitor
0,052  0,031  Neurokinin antagonist
0,075  0,054  Analgesic, opioid
0,140  0,119  ATPase inhibitor
0,041  0,021  Vesicle monoamine transporter inhibitor
0,197  0,178  CTGF expression inhibitor
0,059  0,040  Ryanodine receptor antagonist
0,114  0,098  Papain-like protease (SARS coronavirus) inhibitor
0,026  0,012  Endothelin A receptor antagonist
0,178  0,165  Antiischemic
0,043  0,030  Acetylcholine M1 receptor agonist
0,093  0,083  UGT2B1 substrate
0,087  0,078  Alpha 2d adrenoreceptor antagonist
0,035  0,026  Ceramide glucosyltransferase inhibitor
0,044  0,036  Opioid mu receptor agonist
0,020  0,013  Vesicular acetylcholine transporter inhibitor
0,037  0,032  Dopamine D5 agonist
0,113  0,107  Neurotrophic factor
0,056  0,051  5 Hydroxytryptamine 2A agonist
0,046  0,042  5 Hydroxytryptamine 2 agonist
0,175  0,170  Antihypoxic
0,123  0,120  Carcinogenic
0,058  0,054  Antiviral (Parainfluenza)
0,148  0,146  Antineoplastic (lymphocytic leukemia)
0,113  0,111  Psychosexual dysfunction treatment
0,046  0,044  Opioid agonist
0,152  0,151  Antineoplastic enhancer
0,028  0,026  Phosphodiesterase 6B inhibitor

